NASDAQ:TSHA | Profit Breakdown | Taysha Gene Therapies, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$0.00-$47.35M-$46.64M
2026-03-31$0.00-$43.49M-$42.41M
2025-12-31$5.49M-$28.3M-$27.85M
2025-09-30$0.00-$34.02M-$32.73M
2025-06-30$1.99M-$26.75M-$26.88M
2025-03-31$2.3M-$21.42M-$21.53M
2024-12-31$2.02M-$19.93M-$18.79M
2024-09-30$1.79M-$25.9M-$25.52M
2024-06-30$1.11M-$21.3M-$20.93M
2024-03-31$3.41M-$24.33M-$24.06M
2023-12-31$3.6M-$16.25M$47.74M
2023-09-30$4.75M-$16.25M-$117.09M
2023-06-30$2.4M-$23.38M-$24.6M
2023-03-31$4.71M-$16.56M-$17.62M
2022-12-31-$53.97M-$55.08M
2022-09-30-$25.46M-$26.53M
2022-06-30-$33.37M-$34.09M
2022-03-31-$49.65M-$50.32M
2021-12-31-$49.72M-$50.39M
2021-09-30-$50.68M-$51.19M
2021-06-30-$40.77M-$40.93M
2021-03-31-$32.09M-$32.02M
2020-12-31-$18.37M-$18.32M
2020-09-30-$15.04M-$15.04M
2020-06-30-$4.01M-$21.22M
2020-03-31-$5.58M-$5.43M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$9.77M-$110.5M-$109M
2024-12-31$8.33M-$91.46M-$89.3M
2023-12-31$15.45M-$72.44M-$111.57M
2022-12-31$2.5M-$162.45M-$166.01M
2021-12-31-$173.27M-$174.52M
2020-12-31-$43M-$60.01M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.